Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker RBCAA
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | Jeff Starke EVP, CHIEF INFORMATION OFFICER | RBCAA Republic Bancorp, Inc. | Sale | 3 | $92.91 | $279 Sale | Form 4 ↗ |
| Oct 29, 2026 | Jeff Starke EVP, CHIEF INFORMATION OFFICER | RBCAA Republic Bancorp, Inc. | Sale | 817 | $92.40 | $75.5K Sale | Form 4 ↗ |
| Jun 11, 2026 | Christy Ames EVP, GENERAL COUNSEL | RBCAA Republic Bancorp, Inc. | Sale | 340 | $87.90 | $29.9K Sale | Form 4 ↗ |
| Jun 10, 2026 | Anthony T. Powell EVP, CHIEF LENDING OFFICER | RBCAA Republic Bancorp, Inc. | Sale | 3,000 | $83.54 | $250.6K Sale | Form 4 ↗ |
| Feb 26, 2026 | Alejandro M. Sanchez Director | RBCAA Republic Bancorp, Inc. | Sale | 1,044 | $71.04 | $74.2K Sale | Form 4 ↗ |
| Feb 26, 2026 | Scott Trager VICE CHAIRMAN, Director, 10% owner | RBCAA Republic Bancorp, Inc. | Buy | 148 | $71.13 | $10.5K Buy | Form 4 ↗ |
| Dec 11, 2025 | Jeff Starke EVP, CHIEF INFORMATION OFFICER | RBCAA Republic Bancorp, Inc. | Sale | 137 | $73.31 | $10.0K Sale | Form 4 ↗ |
| Sep 15, 2025 | Christy Ames EVP, GENERAL COUNSEL | RBCAA Republic Bancorp, Inc. | Sale | 400 | $75.79 | $30.3K Sale | Form 4 ↗ |
| Sep 3, 2025 | Juan Montano EVP, CHIEF MTG BANKING OFFICER | RBCAA Republic Bancorp, Inc. | Sale | 1,223 | $75.53 | $92.4K Sale | Form 4 ↗ |
| Jun 9, 2025 | Christy Ames EVP, GENERAL COUNSEL | RBCAA Republic Bancorp, Inc. | Sale | 700 | $70.50 | $49.4K Sale | Form 4 ↗ |
| Jun 2, 2025 | Scott Trager VICE CHAIRMAN, Director, 10% owner | RBCAA Republic Bancorp, Inc. | Buy | 437 | $68.73 | $30.0K Buy | Form 4 ↗ |
| Jan 30, 2025 | John T. Rippy EVP, CHIEF RISK OFFICER | RBCAA Republic Bancorp, Inc. | Sale | 3,082 | $65.99 | $203.4K Sale | Form 4 ↗ |
| Jan 29, 2025 | David P. Feaster Director | RBCAA Republic Bancorp, Inc. | Sale | 809 | $66.00 | $53.4K Sale | Form 4 ↗ |
| Jan 29, 2025 | David P. Feaster Director | RBCAA Republic Bancorp, Inc. | Sale | 597 | $67.00 | $40.0K Sale | Form 4 ↗ |
| Nov 21, 2024 | Heather V. Howell Director | RBCAA Republic Bancorp, Inc. | Sale | 1,496 | $75.63 | $113.1K Sale | Form 4 ↗ |
15 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:11 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances